New virtual screening strategy identifies existing drug that inhibits COVID-19 virus
A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19.
Read Original Article: New virtual screening strategy identifies existing drug that inhibits COVID-19 virus »
